EDIT- Editas Medicine, Inc.

Name: Editas Medicine, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Editas Medicine, Inc. (EDIT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	O'Neill Gilmore Neil	269.1K	$815.3K	-
VP	Burkly Linda	68.8K	$208.4K	-
Dir	Connaughton Bernadette	37.5K	$113.6K	-
Dir	Levy Elliott M.	37.5K	$113.6K	-
Dir	Hirsch Andrew	37.5K	$113.6K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 3, 2025	Burkly Linda56	EVP, Chief Scientific Officer	Sell	713	$2.15	$1,535.16	-1.0%	-13.7%	-
Dec 3, 2025	O'Neill Gilmore Neil74	CEO	Sell	5,603	$2.15	$12,063.82	-2.0%	-13.7%	-
Dec 3, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	461	$2.15	$992.58	-2.8%	-13.7%	-
Sep 3, 2025	Burkly Linda56	EVP, Chief Scientific Officer	Sell	710	$2.60	$1,843.23	-1.0%	-15.6%	-
Sep 3, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	458	$2.60	$1,189.01	-2.7%	-15.6%	-
Sep 3, 2025	O'Neill Gilmore Neil74	CEO	Sell	5,592	$2.60	$14,517.39	-2.0%	-15.6%	-
Aug 7, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	679	$2.58	$1,751.82	-3.9%	+11.6%	-
Jul 31, 2025	Burkly Linda56	EVP, Chief Scientific Officer	Sell	5,121	$2.49	$12,756.92	-7.4%	+21.1%	-
Jun 3, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	446	$1.72	$768.90	-2.5%	+35.7%	-
Jun 3, 2025	Burkly Linda56	EVP, Chief Scientific Officer	Sell	726	$1.72	$1,251.84	-1.0%	+35.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC